Novavax Nuvaxovid gets full marketing authorization in EU for COVID prevention Ruchika Sharma9 July 2023 10:00 AM ISTGaithersburg: Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M adjuvant, has been granted full Marketing...
Novavax Nuvaxovid gets positive CHMP opinion for full marketing authorization for COVID prevention in EU Ruchika Sharma30 May 2023 2:30 PM ISTGaithersburg: Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M adjuvant, has announced that Nuvaxovid...
Novavax COVID vaccine Nuvaxovid gets extended interim authorization for adolescents in Singapore Ruchika Sharma15 May 2023 11:00 AM ISTNVX-CoV2373 is a protein-based vaccine made by creating copies of the surface spike protein of SARS-CoV-2 that causes COVID.
Novavax Nuvaxovid COVID vaccine approved in Canada for use as primary series in adolescents Ruchika Sharma8 Dec 2022 10:15 AM ISTGaithersburg: Novavax, Inc. has announced that Health Canada has approved a supplement to a New Drug Submission (sNDS) for Nuvaxovid (COVID-19 Vaccine...
Novavax seeks updated Emergency Use Listing from WHO for Nuvaxovid as booster in adults Ruchika Sharma18 Sept 2022 12:30 PM ISTUS: Novavax has announced the submission of a request to the World Health Organization (WHO) to update the Emergency Use Listing (EUL) of Nuvaxovid...
Novavax Nuvaxovid gets expanded conditional marketing authorization in EU for use as booster for adults aged 18 and older Ruchika Sharma14 Sept 2022 1:15 PM ISTGaithersburg: Biotechnology company, Novavax, Inc., has recently announced that the European Commission (EC) has approved the expanded conditional...
Novavax COVID vaccine Nuvaxovid gets expanded conditional marketing nod in UK for adolescents aged 12 through 17 Ruchika Sharma27 Aug 2022 11:15 AM ISTGaithersburg: Novavax, Inc. has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom (UK) has granted...
Novavax COVID vaccine Nuvaxovid gets provisional nod in New Zealand for adolescents aged 12 through 17 Ruchika Sharma22 Aug 2022 1:45 PM ISTNuvaxovid (NVX-CoV2373) is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes...
Novavax COVID jab shows high levels of protection against infection in two large phase-3 trials Ruchika Sharma18 Aug 2022 2:29 PM ISTDr Glenn further said the study was conducted with a vaccine based on the original Wuhan spike protein sequence.
Novavax COVID shot Nuvaxovid must carry warning of heart inflammation, recommends EU Ruchika Sharma4 Aug 2022 12:59 PM IST"We will work with the relevant regulators to assure our product information is consistent with our common interpretation of the incoming data," U.S....
COVID vaccine: Novavax requests WHO to expand Emergency Use Listing of Nuvaxovid for adolescents aged 12 through 17 Ruchika Sharma1 Aug 2022 3:25 PM ISTThe WHO previously granted EUL for Nuvaxovid in adults aged 18 and older in December 2021.
Novavax COVID vaccine Nuvaxovid gets European Commission conditional nod for adolescents Ruchika Sharma6 July 2022 11:36 AM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
